Picture of OptimizeRx logo

OPRX — OptimizeRx News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyAdventurousSmall CapSuper Stock

Brief: OptimizeRx Reports Q4 And Full Year 2021 Financial Results

Feb 24 (Reuters) - Optimizerx Corp  OPRX.O :
    * OPTIMIZERX REPORTS FOURTH QUARTER AND FULL YEAR 2021
FINANCIAL
RESULTS, REVENUE INCREASED 42%, DEMAND FROM LARGE PHARMA GAINS
MOMENTUM
    * Q4 REVENUE ROSE 24 PERCENT TO $20.3 MILLION
    * Q4 NON-GAAP EARNINGS PER SHARE $0.22
    * FOR FULL YEAR 2022, COMPANY EXPECTS NET REVENUES OF $80
MILLION
TO $85 MILLION
    * QTRLY EARNINGS PER SHARE $0.03
    * Q4 EARNINGS PER SHARE VIEW $0.21, REVENUE VIEW $20.2
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX6FG41C 
Further company coverage:  OPRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on OptimizeRx

See all news